Voyager Therapeutics, Inc. - VYGR

SEC FilingsOur VYGR Tweets

About Gravity Analytica

Recent News

  • 11.10.2025 - Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
  • 11.10.2025 - Voyager Reports Third Quarter 2025 Financial and Operating Results
  • 10.01.2025 - Baird's Biotech Discovery Series
  • 10.01.2025 - Baird's Biotech Discovery Series
  • 09.09.2025 - Baird 2025 Global Healthcare Conference
  • 09.09.2025 - Baird 2025 Global Healthcare Conference
  • 09.02.2025 - Citi's 2025 Biopharma Back to School Conference
  • 09.02.2025 - Citi's 2025 Biopharma Back to School Conference
  • 08.26.2025 - Voyager to Present at Upcoming Investor Conferences
  • 08.26.2025 - Voyager to Present at Upcoming Investor Conferences

Recent Filings

  • 10.07.2025 - 4 Statement of changes in beneficial ownership of securities
  • 10.03.2025 - 144 Report of proposed sale of securities
  • 10.03.2025 - 144 Report of proposed sale of securities
  • 09.02.2025 - EX-99.1 EX-99.1
  • 09.02.2025 - 8-K Current report
  • 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2025 - 144 Report of proposed sale of securities
  • 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors